Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jul-23 3:29 PM View:  | Charles River Laboratories ... (CRL) | 03-Jul-23 | Grant | 95 | -- | -- | < 1% 11.51K to 11.6K | |
| 02-Jun-23 10:22 AM View: | Charles River Laboratories ... (CRL) | 31-May-23 | Grant | 338 | -- | -- | 3% 11.17K to 11.51K | |
| 17-May-23 2:43 PM View: | Charles River Laboratories ... (CRL) | 15-May-23 | Grant | 664 | -- | -- | 6% 10.5K to 11.17K | |
| 13-May-22 4:57 PM View: | Charles River Laboratories ... (CRL) | 11-May-22 | Grant | 841 | -- | -- | 9% 9.66K to 10.5K | |
| 12-Jan-22 6:56 PM View: | Rallybio Corp (RLYB) | 11-Jan-22 | Purchase | 4,496 | $10.65 | $47,882.40 | < 1% 714.63K to 719.13K | |
| 12-Jan-22 6:56 PM View: | Rallybio Corp (RLYB) | 10-Jan-22 | Market Purchase | 5,504 | $10.10 | $55,590.40 | < 1% 709.13K to 714.63K | |
| 04-Jan-22 5:06 PM View: | Charles River Laboratories ... (CRL) | 03-Jan-22 | Grant | 63 | -- | -- | < 1% 9.6K to 9.66K | |
| 12-Jan-22 6:56 PM View: | Rallybio Corp (RLYB) | 28-Jul-21 | Acquisition (other) | 272,609 | -- | -- | 100% 0 to 272.61K | |
| 12-Jan-22 6:56 PM View: | Rallybio Corp (RLYB) | 28-Jul-21 | Acquisition (other) | 436,517 | -- | -- | 160% 272.61K to 709.13K | |
| 10-May-21 5:29 PM View: | Charles River Laboratories ... (CRL) | 07-May-21 | Grant | 574 | -- | -- | 6% 9.03K to 9.6K | |
| 12-May-20 2:14 PM View: | Charles River Laboratories ... (CRL) | 11-May-20 | Grant | 1,198 | -- | -- | 15% 7.83K to 9.03K | |
| 23-May-19 1:27 PM View: | Charles River Laboratories ... (CRL) | 22-May-19 | Grant | 2,481 | -- | -- | 46% 5.35K to 7.83K | |
| 16-May-18 6:43 AM View: | Charles River Laboratories ... (CRL) | 14-May-18 | Grant | 2,564 | -- | -- | 92% 2.78K to 5.35K | |
| 03-Aug-17 8:19 AM View: | Charles River Laboratories ... (CRL) | 01-Aug-17 | Grant | 2,782 | -- | -- | 100% 0 to 2.78K | |
| 01-Mar-17 7:45 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 01-Mar-17 | Market Sale | 370 | $132.50 | $49,025.00 | (< 1%) 51.06K to 50.69K | (36%) |
| 01-Mar-17 7:45 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-17 | Grant | 12,800 | -- | -- | 33% 38.88K to 51.68K | |
| 01-Mar-17 7:45 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-17 | Market Sale | 625 | $131.70 | $82,312.50 | (1%) 51.68K to 51.06K | (37%) |
| 01-Mar-17 7:45 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-17 | Market Sale | 860 | $131.20 | $112,832.00 | (2%) 39.74K to 38.88K | (37%) |
| 10-Feb-17 6:05 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-Feb-17 | Market Sale | 217 | $126.84 | $27,524.30 | (< 1%) 39.96K to 39.74K | (42%) |
| 08-Feb-17 4:39 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-17 | Market Sale | 2,728 | $125.70 | $342,904.00 | (6%) 42.69K to 39.96K | (43%) |
| 18-May-16 4:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 16-May-16 | Market Sale | 4,097 | $139.20 | $570,284.00 | (9%) 46.78K to 42.69K | (29%) |
| 01-Mar-16 6:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Feb-16 | Market Sale | 1,000 | $138.91 | $138,910.00 | (2%) 47.78K to 46.78K | (30%) |
| 01-Mar-16 6:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 26-Feb-16 | Grant | 7,000 | -- | -- | 17% 40.78K to 47.78K | |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-16 | Market Sale | 1,966 | $138.09 | $271,481.00 | (5%) 42.75K to 40.78K | (30%) |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 100 | $145.54 | $14,554.00 | < 1% 44.66K to 44.76K | 24% |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 2,005 | $141.56 | $283,823.00 | (4%) 44.76K to 42.75K | (27%) |
| 08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Grant | 11,763 | -- | -- | 36% 32.89K to 44.66K | |
| 05-Aug-15 6:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Aug-15 | Option Exercise | 43,500 | $130.29 | $5,667,490.00 | 132% 32.89K to 76.39K | |
| 05-Aug-15 6:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Aug-15 | Market Option Sale | 43,500 | $196.51 | $8,548,420.00 | (57%) 76.39K to 32.89K | 8% |
| 22-May-15 5:30 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-May-15 | Market Sale | 4,056 | $160.33 | $650,298.00 | (11%) 36.95K to 32.89K | (12%) |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-15 | Market Sale | 370 | $180.34 | $66,725.80 | (< 1%) 37.32K to 36.95K | < 1% |
| 03-Mar-15 9:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-15 | Grant | 5,100 | -- | -- | 16% 32.22K to 37.32K | |
| 12-Feb-15 9:07 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Feb-15 | Market Sale | 3,897 | $173.97 | $677,956.00 | (11%) 36.12K to 32.22K | (3%) |
| 09-Feb-15 8:47 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-15 | Grant | 11,690 | -- | -- | 48% 24.43K to 36.12K | |
| 04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Option Exercise | 9,375 | $104.86 | $983,062.00 | 38% 24.43K to 33.8K | |
| 04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Market Option Sale | 9,375 | $191.52 | $1,795,500.00 | (28%) 33.8K to 24.43K | 6% |
| 13-Jun-14 5:31 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 12-Jun-14 | Option Exercise | 25,000 | $104.86 | $2,621,500.00 | 102% 24.43K to 49.43K | |
| 13-Jun-14 5:31 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 12-Jun-14 | Market Option Sale | 25,000 | $166.42 | $4,160,570.00 | (51%) 49.43K to 24.43K | (8%) |
| 15-May-14 5:11 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-May-14 | Market Sale | 3,574 | $160.85 | $574,878.00 | (13%) 28.0K to 24.43K | (12%) |
| 04-Mar-14 5:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-14 | Grant | 3,000 | -- | -- | 12% 25.0K to 28.0K | |
| 15-May-13 5:24 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 13-May-13 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 01-Mar-10 9:01 PM View: | Pfizer Inc. (PFE) | 25-Feb-10 | Grant | 69,488 | -- | -- | 22% 320.81K to 390.3K | |
| 01-Mar-10 9:01 PM View: | Pfizer Inc. (PFE) | 25-Feb-10 | Payment of Exercise | 1,127 | $17.69 | $19,936.60 | (< 1%) 390.3K to 389.17K | (139%) |
| 02-Mar-09 6:27 PM View: | Pfizer Inc. (PFE) | 26-Feb-09 | Grant | 136,982 | -- | -- | 77% 178.02K to 315.0K | |
| 02-Mar-09 6:27 PM View: | Pfizer Inc. (PFE) | 26-Feb-09 | Payment of Exercise | 5,837 | $12.70 | $74,129.90 | (2%) 315.0K to 309.17K | (271%) |
| 03-Mar-08 8:04 PM View: | Pfizer Inc. (PFE) | 28-Feb-08 | Grant | 44,608 | -- | -- | 36% 124.93K to 169.54K | |
| 03-Mar-08 8:04 PM View: | Pfizer Inc. (PFE) | 28-Feb-08 | Payment of Exercise | 1,604 | $22.55 | $36,170.20 | (< 1%) 169.54K to 167.93K | (91%) |
| 01-Nov-07 4:53 PM View: | Pfizer Inc. (PFE) | 31-Oct-07 | Grant | 6,250 | -- | -- | 5% 116.13K to 122.38K |